Combination therapy shows promise for hereditary papillary kidney cancer
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated papillary RCC is [...]
Unprecedented boost for clinical trials under 10 Year Health Plan
The government's new 10 Year Health Plan, due to be [...]
Kidney cancer research highlights from ASCO 2025
Every year, researchers from around the world gather at a [...]
